CLINICAL_TRIALS
trial_result
· 2020-10-19
Clinical Trial Update: Extension Study of Ataluren (PTC124) in Cystic Fibrosis [Phase 3]
Summary
Extension study update for ataluren (PTC124) in cystic fibrosis; Phase 3 completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PTC Therapeutics | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2020-10-19